教員紹介トップページへ | 三重大学トップページへ |
職名 | 講師 | |||||||||
氏名 | まつもと たけし 松本 剛史 |
|||||||||
生年月 | 1968.06 | |||||||||
|
||||||||||
TEL | ||||||||||
FAX | 059-231-5216 | |||||||||
matsutak@clin............... | ||||||||||
個人のホームページ | ||||||||||
学歴 | 山口大学医学部医学科 学士課程 (~1997年03月) 卒業・修了
三重大学大学院医学系研究科 博士課程・博士後期課程 (~2006年12月) 卒業・修了 |
|||||||||
学位 | 2006.12 博士(医学) 三重大学
|
|||||||||
所属学会 | 日本血液学会 日本血栓止血学会 日本輸血・細胞治療学会 日本内科学会 日本エイズ学会 日本検査血液学会 日本臨床検査医学会 International Society on Thrombosis and Haemostasis The World Federation of Hemophilia 日本感染症学会 | |||||||||
社会活動 | ||||||||||
職歴 | 1998~ 三重大学医学部第二内科入局
2007.04~2008.03 三重大学医学部附属病院 内科系診療科 医員 2008.04~2008.05 三重大学医学部附属病院 輸血部 医員 2008.06~2017.09 三重大学医学部附属病院 輸血部 助教 2008.12~2017.09 三重大学医学部附属病院 輸血部 副部長 2017.10~2021.03 三重大学医学部附属病院 輸血・細胞治療部 助教・副部長 2021.04~ 三重大学医学部附属病院 輸血・細胞治療部 講師・副部長 |
|||||||||
学術(芸術)賞 | ||||||||||
専門分野 | 血液内科
血栓止血学 輸血医学 |
|||||||||
現在の研究課題 | 血友病 血栓 止血 凝固 HIV感染症 輸血医学 | |||||||||
担当科目 | 血栓・止血・凝固・輸血 | |||||||||
主な業績等 | ADAMTS13 related markers and von Willebrand factor in plasma from patients with thrombotic microangiopathy (TMA). 共著 2008 Thrombosis research 121 849-54
Central venous catheter-related thrombosis after replacement therapy for intracranial bleeding in a patient with afibrinogenaemia. 共著 2008.01 Haemophilia : the official journal of the World Federation of Hemophilia 14 153-6 Negative predictive value of D-dimer for diagnosis of venous thromboembolism. 共著 2008.04 International journal of hematology 87 250-5 The membrane proteinase 3 expression on neutrophils was downregulated after treatment with infliximab in patients with rheumatoid arthritis. 共著 2008.04 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 14 186-92 Elevated levels of soluble fibrin in patients with venous thromboembolism. 共著 2008.11 International journal of hematology 88 448-53 The effectiveness of measuring for fragmented red cells using an automated hematology analyzer in patients with thrombotic microangiopathy. 2009.05 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 15 257-62 Decreased ADAMTS13 levels in patients after living donor liver transplantation. 共著 2009.11 Thrombosis research 124 541-5 Analysis three abnormal Protein S genes in a patient with pulmonary embolism. 共著 2010.06 Thrombosis research 125 529-32 Elevated Von Willebrand factor propeptide for the diagnosis of thrombotic microangiopathy and for predicting a poor outcome. 共著 2011.01 International journal of hematology 93 47-52 Monitoring for anti-Xa activity for prophylactic administration of Fondaparinux in patients with artificial joint replacement. 共著 2011.10 International journal of hematology 94 355-60 A case of three-year-old boy with severe haemophilia A on prophylaxis identified with a chronic subdural haematoma 2 years after the first episode of acute subdural bleeding. 共著 2012.01 Haemophilia : the official journal of the World Federation of Hemophilia 18 e1-2 Increased fibrinolysis increases bleeding in orthopedic patients receiving prophylactic fondaparinux. 共著 2012.02 International journal of hematology 95 160-6 Frequent association of thrombophilia in cerebral venous sinus thrombosis. 共著 2012.03 International journal of hematology 95 257-62 Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases. 2012.05 Thrombosis research 129 598-602 Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases. 共著 2012.05 Thrombosis research 129 598-602 Diagnostic criteria and laboratory tests for disseminated intravascular coagulation. 2012.12 Expert review of hematology 5 643-52 A prospective analysis of disseminated intravascular coagulation in patients with infections. 共著 2013 Internal medicine (Tokyo, Japan) 52 1893-8 Behavior of ADAMTS13 and Von Willebrand factor levels in patients after living donor liver transplantation. 共著 2013.03 Thrombosis research 131 225-9 Presence of antiphospholipid antibody is a risk factor in thrombotic events in patients with antiphospholipid syndrome or relevant diseases. 共著 2013.03 International journal of hematology 97 345-50 The relationships among hemostatic markers, the withdrawal of fondaparinux due to a reduction in hemoglobin and deep vein thrombosis in Japanese patients undergoing major orthopedic surgery. 共著 2013.10 Clinica chimica acta; international journal of clinical chemistry 425 109-13 Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. 共著 2014 Journal of intensive care 2 15- Elevated fibrin-related markers in patients with malignant diseases frequently associated with disseminated intravascular coagulation and venous thromboembolism. 共著 2014 Internal medicine (Tokyo, Japan) 53 413-9 Disseminated intravascular coagulation: Testing and diagnosis. 共著 2014.04 Clinica chimica acta; international journal of clinical chemistry Is early treatment of disseminated intravascular coagulation beneficial in septic patients? 共著 2014.07 Critical care (London, England) 18 447- Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial. 共著 2014.10 Journal of hypertension 32 2054-63; discussiom 2063 Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation. 2014.11 International journal of hematology 100 437-42 Elevated soluble platelet glycoprotein VI is a useful marker for DVT in postoperative patients treated with edoxaban. 共著 2014.11 International journal of hematology 100 450-6 Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. 共著 2014.11 Seminars in thrombosis and hemostasis 40 866-73 Successful treatment of non-invasive bladder tumour in a haemophilia A patient with high-responding inhibitors: a case report. 共著 2014.11 Haemophilia : the official journal of the World Federation of Hemophilia 20 e399-401 Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study: comment. 2015.04 Journal of thrombosis and haemostasis : JTH 13 679-80 Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: comment on two papers. 共著 2015.04 Journal of thrombosis and haemostasis : JTH 13 684-5 New Insights of the Tissue Factor Pathway Inhibitor in Patients with Hypercholesterolemia Treated with Statins. 共著 2015.07 Journal of atherosclerosis and thrombosis 22 654-5 High frequency of decreased antithrombin level in pregnant women with thrombosis. 共著 2015.09 International journal of hematology 102 253-8 Presence of Antiphospholipid Antibodies as a Risk Factor for Thrombotic Events in Patients with Connective Tissue Diseases and Idiopathic Thrombocytopenic Purpura. 2016 Internal medicine (Tokyo, Japan) 55 589-95 The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC. 共著 2016.02 International journal of hematology 103 173-9 Comparison of three different anti-Xa assays in major orthopedic surgery patients treated with fondaparinux. 共著 2016.05 International journal of hematology 103 554-9 Fibrin-related markers for diagnosing acute-, subclinical-, and pre-venous thromboembolism in patients with major orthopedic surgery. 共著 2016.05 International journal of hematology 103 560-6 Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH: comment. 共著 2016.06 Journal of thrombosis and haemostasis : JTH 14 1314-5 Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials: comment. 共著 2016.11 Journal of thrombosis and haemostasis : JTH 14 2308-2309 Shock, acute disseminated intravascular coagulation, and microvascular thrombosis: is 'shock liver' the unrecognized provocateur of ischemic limb necrosis: comment. 共著 2016.11 Journal of thrombosis and haemostasis : JTH 14 2315-2316 The valuable diagnosis of DIC and pre-DIC and prediction of a poor outcome by the evaluation of diagnostic criteria for DIC in patients with hematopoietic injury established by the Japanese Society of Thrombosis and Hemostasis. 共著 2016.11 Thrombosis research 147 80-84 Comparison of three different anti-Xa assays in major orthopedic surgery patients treated with direct oral anticoagulant. 共著 2017 Thrombosis journal 15 27- Hypofibrinogenemia and the alpha-Fibrinogen Thr312Ala Polymorphism may be Risk Factors for Early Pregnancy Loss. 共著 2017.01 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 23 52-57 The Evaluation of D-Dimer Levels for the Comparison of Fibrinogen and Fibrin Units Using Different D-Dimer Kits to Diagnose VTE. 共著 2017.01 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 1076029617706755- High prevalence of congenital thrombophilia in patients with pregnancy-related or idiopathic venous thromboembolism/pulmonary embolism. 2017.03 International journal of hematology 105 272-279 Elevated Soluble Platelet Glycoprotein VI Levels in Patients After Living Donor Liver Transplantation. 共著 2017.04 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 23 274-281 An Evaluation of the Modified Diagnostic Criteria for DIC Established by the Japanese Society of Thrombosis and Hemostasis. 共著 2017.09 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 23 579-584 Plasma ADAMTS13, von Willebrand Factor (VWF), and VWF Propeptide Profiles in Patients With Connective Tissue Diseases and Antiphospholipid Syndrome. 共著 2017.09 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 23 622-630 Attempt to Harvest a Sufficient Number of Mononuclear Cells in an Appropriate Blood Product Volume By Modification of the Default Apheresis Setting. 共著 2017.10 Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Soc 21 507-511 Evaluation of the Diagnostic Criteria for the Basic Type of DIC Established by the Japanese Society of Thrombosis and Hemostasis. 共著 2017.10 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 23 838-843 Emicizumab Prophylaxis in Hemophilia A with Inhibitors. 共著 2017.11 The New England journal of medicine 377 2193-4 Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy. 2018 Thrombosis journal 16 14- The Evaluation of Fibrin-Related Markers for Diagnosing or Predicting Acute or Subclinical Venous Thromboembolism in Patients Undergoing Major Orthopedic Surgery. 共著 2018.01 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 24 107-114 Monitoring of hemostatic abnormalities in major orthopedic surgery patients treated with edoxaban by APTT waveform. 2018.02 International journal of laboratory hematology 40 49-55 The Evaluation of D-Dimer Levels for the Comparison of Fibrinogen and Fibrin Units Using Different D-Dimer Kits to Diagnose VTE. 共著 2018.05 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 24 655-662 Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa/factor X bispecific antibody emicizumab: comment. 2018.06 Journal of thrombosis and haemostasis : JTH 【出血性疾患と血栓性疾患 これを読めば貴方も二刀流】 セミナー 実地医家が知っておくべき最新の知見 血栓性微小血管症(TMA)の鑑別診断 共著 2018.07 Medical Practice 35 1061-1065 An Evaluation of the Activated Partial Thromboplastin Time Waveform. 共著 2018.07 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/H 24 764-770 An Evaluation of the Activated Partial Thromboplastin Time Waveform. 共著 2018.07 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 24 764-770 The Plasma Levels of ADAMTS-13, von Willebrand Factor, VWFpp, and Fibrin-Related Markers in Patients With Systemic Sclerosis Having Thrombosis. 共著 2018.09 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 24 920-927 An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform. 共著 2018.10 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 24 1170-1176 Congenital Thrombophilia in Patients With Superior Mesenteric Venous Thrombosis or Portal Vein Thrombosis. 共著 2018.10 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 24 1117-1121 【徹底ガイド DICのすべて 2019-20】(VIII章)基礎病態と治療 造血器悪性腫瘍 単著 2018.11 救急・集中治療 30 229-233 【徹底ガイド DICのすべて 2019-20】(VII章)診断と治療の指針 ISTH DIC診療ガイダンス 共著 2018.11 救急・集中治療 30 229-233 Clinical Manifestation of Patients With Atypical Hemolytic Uremic Syndrome With the C3 p.I1157T Variation in the Kinki Region of Japan. 共著 2018.11 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 24 1301-1307 【血栓止血の臨床-研修医のために[第2版]】出血性疾患の治療(血液製剤など) 新鮮凍結血漿の適正使用 単著 2018.12 日本血栓止血学会誌 29 734-736 Usefulness of the APTT waveform for the diagnosis of DIC and prediction of the outcome or bleeding risk. 共著 2019 Thrombosis journal 17 12- Comments to: An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia by APTT Waveform, Peak Heights of APTT Waveform Are Useful for Diagnosing Hemophilia or Inhibitor. 単著 2019.01 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/H 25 1076029618824419- Comments to: An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia by APTT Waveform, Peak Heights of APTT Waveform Are Useful for Diagnosing Hemophilia or Inhibitor. 2019.01 Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/He 25 1076029618824419- Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti-idiotype monoclonal antibodies: comment. 共著 2019.03 Journal of thrombosis and haemostasis : JTH 17 555-556 Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti-idiotype monoclonal antibodies: comment. 共著 2019.03 Journal of thrombosis and haemostasis : JTH 17 555-556 Clinicopathological features of TAFRO syndrome complicated by acquired hemophilia A and development of cardiopulmonary arrest that were successfully treated with VA-ECMO and tocilizumab. 2019.06 International journal of hematology 109 737-743 Life-Threatening Tongue and Retropharyngeal Hemorrhage in a Patient with Hemophilia A with Inhibitors. 共著 2019.07 The American journal of case reports 20 1022-1026 |